Morgan Stanley boosted the size of its latest offering of X Holdings Corp. debt to $4.74 billion, putting the firm and other ...

Morgan Stanley is finalizing the sale of another $3 billion of X Holdings Corp. debt, making further progress in a years-long ...

It is the third transaction in a frenetic period of less than a month, during which Morgan Stanley led a group of seven Wall ...

Wall Street banks led by Morgan Stanley (MS) are close to offloading another $3 billion in debt relating to Elon Musk’s purchase of ...

Morgan Stanley advised Musk on the purchase, led the financing and sales and also held the largest chunk of X debt. Other ...

The sales mark a surprising turnaround for what had initially been seen as an ill-fated financing of Musk's 2022 takeover of ...

Banks led by Morgan Stanley have sold to investors another chunky portion of loans that formed the $13 billion debt ...

Investing.com -- Morgan Stanley (NYSE: MS) is reportedly planning to increase the size of its latest X Holdings Corp. debt ...

Morgan Stanley kicked off another large sale of X Corp debt, seizing on investors’ sudden embrace of the social media ...

Morgan Stanley is boosting the size of its latest offering of X Holdings Corp. debt to $4.74 billion with no discount, further reducing exposure.

Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Under Mr. Pick's leadership in 2024, Morgan Stanley saw net revenues reach a record $61.8 billion, a 14% increase from the previous year, with net income applicable to the firm at approximately $13.4 ...